Italy Food Allergy Diagnosis Treatment Market

Italy Food Allergy Diagnosis and Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies) and By Age Group (Children, Adults, Elderly) - Growth & Industry Forecast 2025 To 2035
ID: MRFR/HC/51347-HCR 200 Pages Vikita Thakur, Rahul Gotadki Last Updated: September 17, 2026
Italy Food Allergy Diagnosis Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.51%
2024 Market Size$ 61.92 Million
2025 Market Size$ 66.57 Million
2035 Market Size$ 137.4 Million
Key Players
Thermo Fisher Scientific
Danone
Nestle
Abbott Laboratories
Bayer AG
Mylan N.V.
Trends
  • Rising Prevalence of Food Allergies
  • Advancements in Diagnostic Technologies
  • Regulatory Changes and Food Safety
Opportunities
  • Government Initiatives and Funding
  • Increased Awareness of Food Allergies
  • Rising Incidence of Anaphylaxis Cases
Request Free Sample

Italy Food Allergy Diagnosis Treatment Market Summary

As per Market Research Future analysis, the Italy food allergy-diagnosis-treatment market size was estimated at 61.92 USD Million in 2024. The Italy food allergy-diagnosis-treatment market is projected to grow from 66.57 USD Million in 2025 to 137.4 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.5% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Italy food allergy-diagnosis-treatment market is experiencing notable growth driven by increasing awareness and technological advancements.

  • The market is witnessing a rising prevalence of food allergies, particularly among children and young adults.
  • Advancements in diagnostic technologies are enhancing the accuracy and speed of food allergy testing.
  • The largest segment in this market is diagnostic testing, while the fastest-growing segment is treatment.
  • Key market drivers include increased awareness of food allergies and consumer demand for allergen-free products.

Market Size & Forecast

2024 Market Size 61.92 (USD Million)
2035 Market Size 137.4 (USD Million)
CAGR (2025 - 2035) 7.51%

Major Players

Thermo Fisher Scientific (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Bayer AG (DE), Mylan N.V. (US), Aimmune Therapeutics (US), DBV Technologies (FR), Allergan (IE)

Italy Food Allergy Diagnosis Treatment Market Drivers

Government Initiatives and Funding

Government initiatives aimed at improving food safety and allergy management are playing a pivotal role in shaping the food allergy-diagnosis-treatment market. In Italy, the government has implemented various programs to enhance public health awareness and provide funding for research into food allergies. These initiatives not only support the development of new diagnostic tools and treatments but also promote collaboration between public health agencies and private sector stakeholders. As a result, the market is likely to benefit from increased investment in research and development, leading to innovative solutions that address the growing needs of individuals with food allergies.

Increased Awareness of Food Allergies

The growing awareness of food allergies among the Italian population is a crucial driver for the food allergy-diagnosis-treatment market. Educational campaigns and initiatives by health organizations have led to heightened public consciousness regarding the symptoms and risks associated with food allergies. This awareness is reflected in the increasing number of individuals seeking medical advice and diagnostic testing. In Italy, it is estimated that approximately 3 million people are affected by food allergies, which represents around 5% of the population. As more individuals recognize the importance of early diagnosis and management, the demand for specialized treatments and diagnostic services is likely to rise, thereby propelling the market forward.

Rising Incidence of Anaphylaxis Cases

The increasing incidence of anaphylaxis cases in Italy is a significant driver for the food allergy-diagnosis-treatment market. Anaphylaxis, a severe allergic reaction, can be life-threatening and requires immediate medical intervention. Recent studies indicate that hospital admissions for anaphylaxis have risen by 20% over the past five years, highlighting the urgent need for effective diagnosis and treatment options. This alarming trend has prompted healthcare providers to prioritize allergy management and education, leading to a surge in demand for diagnostic services and treatment protocols. Consequently, the food allergy-diagnosis-treatment market is expected to expand as healthcare systems adapt to address this critical public health issue.

Consumer Demand for Allergen-Free Products

The rising consumer demand for allergen-free products is a notable driver for the market. As more individuals become aware of their food allergies, there is a corresponding increase in the demand for safe, allergen-free food options. In Italy, the market for allergen-free foods is projected to reach €1 billion by 2026, reflecting a growing trend towards healthier eating habits. This shift in consumer preferences is encouraging food manufacturers to develop products that cater to those with food allergies, thereby creating a more extensive market for diagnostic and treatment services. The food allergy-diagnosis-treatment market is thus positioned to grow in response to these evolving consumer needs.

Technological Innovations in Allergy Testing

Technological advancements in allergy testing methods are significantly influencing the food allergy-diagnosis-treatment market. Innovations such as molecular diagnostics and skin prick tests have improved the accuracy and speed of allergy identification. In Italy, the introduction of point-of-care testing devices has made it easier for healthcare providers to diagnose food allergies promptly. These technologies not only enhance patient outcomes but also reduce the overall healthcare costs associated with misdiagnosis or delayed treatment. The market for these advanced diagnostic tools is projected to grow at a CAGR of 8% over the next five years, indicating a robust demand for innovative solutions in the food allergy-diagnosis-treatment market.

Market Segment Insights

By Diagnosis Method: Skin Prick Test (Largest) vs. Blood Test (Fastest-Growing)

In the Italy food allergy-diagnosis-treatment market, the Skin Prick Test dominates the Diagnosis Method segment, capturing a significant share due to its effectiveness and established procedures. Blood Tests follow closely, offering an alternative choice for patients who may prefer a less invasive method. The Oral Food Challenge and Elimination Diet are smaller segments but play crucial roles in precise diagnostics and treatment protocols that enhance patient management and safety. Growth trends in the Diagnosis Method segment are largely driven by increasing awareness of food allergies and advancements in diagnostic technologies. Skin Prick Tests continue to be favored due to their reliability, while Blood Tests show rapid growth, attributed to their non-invasive nature and the rise in allergy awareness. Additionally, a growing population seeking solutions for food allergies stimulates the development of these testing methods, facilitating better healthcare outcomes.

Skin Prick Test (Dominant) vs. Blood Test (Emerging)

The Skin Prick Test is a dominant player in the Italy food allergy-diagnosis-treatment market, recognized for its quick results and cost-effectiveness. This method typically demonstrates high sensitivity and specificity in identifying allergic reactions, making it a preferred choice among healthcare providers. In contrast, the Blood Test is emerging rapidly as a viable alternative, appealing to patients due to its less invasive nature. It measures specific IgE antibodies and provides a comprehensive approach to allergy testing. As patients become more concerned about invasive procedures, the Blood Test's market share is expected to grow, driven by technological advancements and an increasing focus on patient-centered care.

By Treatment Type: Medication (Largest) vs. Immunotherapy (Fastest-Growing)

In the Italy food allergy-diagnosis-treatment market, the treatment type segment is characterized by a diverse distribution of its values. Medication holds the largest share, catering to a broad range of allergic reactions and ensuring immediate relief for patients. Immunotherapy, meanwhile, is rapidly gaining traction due to its promising results in providing long-term solutions by gradually desensitizing patients to allergens. This segment also reflects a growing consumer preference for sustainable and enduring treatment options. The growth trends within this segment are primarily driven by advancements in medical research and increasing awareness of food allergies among the general population. As healthcare providers emphasize personalized treatment plans, dietary management is also becoming a significant aspect, allowing patients to tailor their diets according to their individual allergies. Emergency treatment devices are witnessing heightened demand as safety measures are prioritized in managing severe allergic reactions.

Medication (Dominant) vs. Immunotherapy (Emerging)

Medication, as a dominant segment, encompasses a wide range of pharmaceuticals used to manage food allergies effectively. This includes antihistamines, corticosteroids, and other therapeutic agents that provide quick relief from acute symptoms. The accessibility and comprehensive nature of medication make it the first line of defense for many patients. On the other hand, immunotherapy represents an emerging and innovative approach, designed to modify the immune response to allergens. As clinical trials continue to showcase promising results, immunotherapy is anticipated to grow rapidly, attracting attention from both patients and healthcare professionals. Together, these segments highlight the evolving landscape of treatment options available to individuals dealing with food allergies.

By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the Italy food allergy-diagnosis-treatment market, the distribution among end users is notably diverse. Hospitals continue to dominate this space, driven by the comprehensive facilities they offer for diagnosis and treatment. Clinics, on the other hand, are rapidly gaining ground, leveraging specialized services to cater to a growing number of patients facing food allergies. The growth trends in this segment are influenced by the increasing prevalence of food allergies and the heightened awareness regarding diagnostic procedures. Hospitals are expanding their allergy departments, while clinics are embracing innovative treatment methods, making them an emerging choice for patients. The shift toward personalized care and convenience further accelerates the growth of clinics as a viable alternative to traditional hospital care.

Hospitals: Dominant vs. Clinics: Emerging

Hospitals serve as the dominant force in the Italy food allergy-diagnosis-treatment market due to their extensive resources and integrated care pathways. They provide comprehensive services ranging from diagnosis to treatment, thus ensuring a high level of trust among patients. Clinics, while emerging, are particularly focused on specific specialties, offering tailored services that can lead to faster diagnosis and treatment times. This flexibility, along with their ability to operate at lower costs, positions clinics to capture a larger share of the market, especially among patients seeking less formal settings for their allergy-related health issues.

By Age Group: Children (Largest) vs. Elderly (Fastest-Growing)

In the Italy food allergy-diagnosis-treatment market, the age group segment displays a varied distribution of market shares among Children, Adults, and the Elderly. Children constitute the largest segment, driven by the rising prevalence of allergies in younger populations, necessitating specialized diagnostic and treatment solutions. Adults follow closely but are witnessing a stable growth rate, while the Elderly, although currently a smaller segment, shows significant potential for expansion due to the increasing aging population and a higher incidences of allergies in older adults. Growth trends in this segment indicate an overall increase in demand for allergy-related services and products across all age groups. The driving forces behind this growth include heightened awareness about food allergies, advancements in diagnostic technologies, and the growing adoption of personalized treatment plans. Rising disposable incomes also allow families to seek better healthcare options, further boosting the market. The Elderly segment is particularly influenced by the rising healthcare expenditure and a focus on quality of life improvements, positioning it as the fastest-growing segment.

Children (Dominant) vs. Elderly (Emerging)

The Children segment is dominant in the Italy food allergy-diagnosis-treatment market, owing to a sharp rise in diagnosed cases of food allergies in younger populations. This group has unique needs, necessitating specialized treatments and services tailored to children. Pediatric allergists and nutritionists play a critical role in addressing these needs, offering both medical and dietary interventions. In contrast, the Elderly segment, although currently smaller, is emerging rapidly. As the population ages, there is a significant increase in allergies related to aging and comorbidities. This segment requires tailored diagnostic approaches and treatment options, driving innovation in the market and presenting unique challenges to healthcare providers. Both segments emphasize the need for heightened awareness and specialized care.

Get more detailed insights about Italy Food Allergy Diagnosis Treatment Market
Request Free Sample

Key Players and Competitive Insights

The food allergy-diagnosis-treatment market in Italy is characterized by a dynamic competitive landscape, driven by increasing awareness of food allergies and the rising prevalence of allergic conditions among the population. Key players such as Thermo Fisher Scientific (US), Danone (FR), and Aimmune Therapeutics (US) are actively shaping the market through innovative product offerings and strategic partnerships. Thermo Fisher Scientific (US) focuses on enhancing its diagnostic capabilities, while Danone (FR) emphasizes the development of specialized nutritional products for allergy management. Aimmune Therapeutics (US) is advancing its immunotherapy solutions, indicating a trend towards personalized treatment options that cater to individual patient needs. Collectively, these strategies contribute to a competitive environment that prioritizes innovation and patient-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce costs. This approach not only supports faster product delivery but also aligns with the growing demand for locally sourced solutions. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies remains substantial, as they leverage their resources to establish a strong foothold in the market.

In October Danone (FR) announced the launch of a new line of hypoallergenic infant formulas designed to address the nutritional needs of children with food allergies. This strategic move is significant as it aligns with the increasing demand for specialized dietary products, particularly among parents seeking safe options for their allergic children. By expanding its product portfolio, Danone (FR) not only enhances its market presence but also reinforces its commitment to addressing food allergy challenges.

In September Aimmune Therapeutics (US) received regulatory approval for its latest oral immunotherapy product aimed at peanut allergies. This approval marks a pivotal moment for the company, as it positions Aimmune Therapeutics (US) as a leader in the immunotherapy segment. The introduction of this product is expected to significantly impact treatment paradigms, offering patients a viable option to manage their allergies effectively.

In August Thermo Fisher Scientific (US) unveiled a new diagnostic platform that integrates advanced AI technologies to improve the accuracy of food allergy testing. This innovation is crucial in a market where precise diagnosis is paramount for effective treatment. By harnessing AI, Thermo Fisher Scientific (US) not only enhances its diagnostic capabilities but also sets a new standard for the industry, potentially influencing competitors to adopt similar technologies.

As of November current trends in the food allergy-diagnosis-treatment market indicate a strong shift towards digitalization and sustainability. Companies are increasingly forming strategic alliances to enhance their technological capabilities and expand their market reach. This collaborative approach is likely to redefine competitive differentiation, moving away from traditional price-based competition towards a focus on innovation, technology integration, and supply chain reliability. The future landscape may see companies that prioritize these elements gaining a competitive edge, ultimately benefiting patients through improved treatment options and outcomes.

Key Companies in the Italy Food Allergy Diagnosis Treatment Market include

Recent Industry Developments

Recent developments in the Italy Food Allergy Diagnosis and Treatment Market showcase significant advancements and ongoing challenges. In July 2023, Abbott Laboratories introduced a novel diagnostic tool aimed at enhancing the precision of food allergy identification in Italian healthcare settings, addressing the rising prevalence of food allergies in the country. Meanwhile, in August 2023, Merck announced a partnership with local biotech firms to expedite R&D processes in allergy treatment solutions. August 2023 also marked the acquisition of a small Italian company by GSK, focusing on innovative therapies for food allergies, reflecting the trend towards consolidation in the healthcare sector. 

The market has seen a considerable increase in valuation, driven by heightened consumer awareness and legislative support for food allergy research. Over the past few years, notable changes included advancements in desensitization therapies in early 2022. Furthermore, the Italian Ministry of Health has prioritized food allergy policies, allocating resources for detection and management, thereby influencing the market dynamics. Companies like Nestle and Bayer are also focusing more on allergy-friendly food alternatives, indicating a shift towards consumer-driven demand in Italy's food sector.

Future Outlook

Italy Food Allergy Diagnosis Treatment Market Future Outlook

The market in Italy is projected to grow at a 7.51% CAGR from 2025 to 2035, driven by increasing prevalence and advancements in diagnostic technologies.

New opportunities lie in:

  • Development of AI-driven diagnostic tools for personalized treatment plans.
  • Expansion of telehealth services for remote allergy consultations.
  • Investment in allergen-free food product lines to capture niche markets.

By 2035, the market is expected to be robust, driven by innovation and increased consumer awareness.

Market Segmentation

Italy Food Allergy Diagnosis Treatment Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care
  • Pharmaceutical Companies

Italy Food Allergy Diagnosis Treatment Market Age Group Outlook

  • Children
  • Adults
  • Elderly

Italy Food Allergy Diagnosis Treatment Market Treatment Type Outlook

  • Medication
  • Immunotherapy
  • Dietary Management
  • Emergency Treatment Devices

Italy Food Allergy Diagnosis Treatment Market Diagnosis Method Outlook

  • Skin Prick Test
  • Blood Test
  • Oral Food Challenge
  • Elimination Diet

Report Scope

MARKET SIZE 2024 61.92(USD Million)
MARKET SIZE 2025 66.57(USD Million)
MARKET SIZE 2035 137.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.51% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Thermo Fisher Scientific (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Bayer AG (DE), Mylan N.V. (US), Aimmune Therapeutics (US), DBV Technologies (FR), Allergan (IE)
Segments Covered Diagnosis Method, Treatment Type, End User, Age Group
Key Market Opportunities Advancements in personalized medicine enhance food allergy-diagnosis-treatment market potential through tailored therapeutic approaches.
Key Market Dynamics Rising consumer awareness drives demand for innovative food allergy diagnosis and treatment solutions in Italy.
Countries Covered Italy

Frequently Asked Questions

What is the current valuation of the food allergy-diagnosis-treatment market in Italy as of 2024?

The market valuation was $61.92 Million in 2024.

What is the projected market valuation for the food allergy-diagnosis-treatment market in Italy by 2035?

The projected valuation for 2035 is $137.4 Million.

What is the expected CAGR for the food allergy-diagnosis-treatment market in Italy during the forecast period 2025 - 2035?

The expected CAGR during this period is 7.51%.

Which diagnostic methods are most prominent in the food allergy-diagnosis market in Italy?

Key diagnostic methods include Blood Tests, valued at $46.12 Million, and Skin Prick Tests, valued at $34.12 Million.

What are the leading treatment types in the food allergy market in Italy?

Leading treatment types include Dietary Management, valued at $45.78 Million, and Medication, valued at $34.12 Million.

Who are the key players in the food allergy-diagnosis-treatment market in Italy?

Key players include Thermo Fisher Scientific, Danone, Nestle, and Abbott Laboratories.

What is the market segmentation by end user in the food allergy-diagnosis-treatment market in Italy?

End users include Hospitals, valued at $46.12 Million, and Clinics, valued at $36.12 Million.

How does the age group segmentation look in the food allergy market in Italy?

The age group segmentation shows Adults leading with $70.0 Million, followed by Children at $35.0 Million.

What is the valuation of the Oral Food Challenge diagnostic method in the Italian market?

The Oral Food Challenge is valued at $28.56 Million in the market.

What is the valuation of Emergency Treatment Devices in the food allergy treatment market in Italy?

Emergency Treatment Devices are valued at $29.94 Million.

Author
Author Author Profile Vikita Thakur LinkedIn Senior Research Analyst
She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.
Co-Author Co-Author Profile Rahul Gotadki LinkedIn Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.